Nasdaq: AMLX
Amylyx Pharmaceuticals insiders
The officers, directors and 10% owners of Amylyx Pharmaceuticals, Inc. who hold the most stock, valued at the live AMLX price.
$26.20
AMLX today −$420K (−1.58%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 10
- Their AMLX stock
- $580M
- Market value
- $3.37B
- Held by ranked insiders
- 17.2%
Insiders by value of AMLX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | ALS Invest 1 B.V. | 10% owner | 5,895,280 | $154M | 4.59% | Corporate |
| 2 | Morningside Venture Investments Ltd | 10% owner | 4,997,302 | $131M | 3.89% | Corporate |
| 3 | Joshua B. Cohen | Co-Chief Executive Officer | 3,513,123 | $92.0M | 2.73% | 1598th |
| 4 | Justin B. Klee | Co-Chief Executive Officer | 3,513,056 | $92.0M | 2.73% | 1599th |
| 5 | Dragsa 96 LLC | 10% owner | 2,300,000 | $60.3M | 1.79% | Corporate |
| 6 | George M. Milne Jr. | Director | 782,881 | $20.5M | 0.61% | 4876th |
| 7 | James M. Frates | Chief Financial Officer | 384,697 | $10.1M | 0.30% | 8734th |
| 8 | Camille L. Bedrosian | Chief Medical Officer | 278,064 | $7.3M | 0.22% | 9589th |
| 9 | Margaret Olinger | Chief Commercial Officer | 276,108 | $7.2M | 0.21% | 11150th |
| 10 | Patrick D. Yeramian | Chief Medical Officer | 205,605 | $5.4M | 0.16% | 13745th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Amylyx Pharmaceuticals; see each profile for the filing.